Photodynamic Therapy by Topical Aminolevulinic Acid, Dimethylsulphoxide and Curettage in Nodular Basal Cell Carcinoma: a One-year Follow-up Study

Maria Soler, Ana; Warloe, Trond; Tausjø, Johan; Berner, Aasmund
May 1999
Acta Dermato-Venereologica;5/27/99, Vol. 79 Issue 3, p204
Academic Journal
Fifty-eight patients with 119 nodular (2 mm or more in thickness) basal cell carcinomas successfully treated with photodynamic therapy were included in this 1-year follow-up study. The initial cure rate at 3-6 months was 92% after photodynamic therapy, which included an initial debulking procedure and topical application of dimethylsulphoxide in order to enhance penetration of 5-aminolevulinic acid (20% in cream) to which the lesions were exposed for 3 h prior to exposure to light. At examination 12-26 months (mean 17 months) after treatment 113 lesions (95%) were still in complete response. Six lesions (5%) had recurred, located on the face, scalp and ear. The cosmetic outcome was evaluated as excellent to good in 91%. Microscopic examination of biopsies taken from healed areas in 7 patients did not reveal any sign of damage in 5 and only minor alterations in 2.


Related Articles

  • Aggressive basal cell carcinomas recurred after photodynamic therapy. Richards, Cassandra A.; Taliercio, Adam; Thiel, Bruce; Volansky, Rob // Hem/Onc Today;10/10/2012, Vol. 13 Issue 19, p58 

    The article discusses research being done on the recurrence of aggressive basal cell carcinomas after photodynamic therapy.

  • MAL-PDT Tc of BCC. Rutledge, Barbara J. // Dermatology Times;May2003, Vol. 24 Issue 5, p36 

    Focuses on the use of photodynamic therapy using methyl aminolevulinate as a photosensitizer in treating primary superficial basal cell carcinoma. Cosmetic results; Recurrence rate.

  • PDT offers good response, recurrence rates for multiple BCCs. Kent, Heather // Dermatology Times;Sep2001, Vol. 22 Issue 9, p56 

    Focuses on the use of ALA-photodynamic therapy (ALA-PDT) in treating patients with multiple superficial basal cell carcinomas (BBC). Efficacy of illumination in healing lesions; Comparison between the efficacy of topical gels and ALA; Optimal time for the diagnosis of BBC through ALA induced...

  • Photodynamic therapy being assessed for basal cell carcinoma.  // Dermatology Times;Mar1997, Vol. 18 Issue 3, p28 

    Focuses on the research done to test the effectiveness of photodynamic therapy in treating basal cell carcinoma (BCC). How the procedure works during treatment; Results of the preliminary studies; Most common side effect of the therapy;

  • Facial basal cell carcinoma. M. Baxter, Julia; N. Patel, Anand; Varma, Sandeep // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/25/2012, Vol. 345 Issue 7871, p37 

    The article focuses on basal cell carcinoma (BCC), a locally invasive cancer of epidermal basaloid cells and the most common cancer in humans. The greatest risk factor for the development of BCC is exposure to ultraviolet radiation. BCC has a variety of clinical presentations. Most BCCs can...

  • Immediate Whealing Urticaria in Red Light Exposed Areas During Photodynamic Therapy. Kaae, Jeanette; Philipsen, Peter A.; Haedersdal, Merete; Wulf, Hans Christian // Acta Dermato-Venereologica;2008, Vol. 88 Issue 5, p480 

    One of the recommended first-line treatments for basal cell carcinomas, actinic keratoses and Bowen's disease is photodynamic therapy. Commonly associated side-effects include pain and phototoxicity. Histamine release is a part of this reaction, but whealing urticaria following photodynamic...

  • PpIX Fluorescence Kinetics and Increased Skin Damage after Intracutaneous Injection of 5-Aminolevulinic Acid and Repeated Illumination. Thissen, Monique R; de Blois, Mieke W; Robinson, Dominic J; de Bruijn, Henriette S; Dutrieux, Richard P; Star, Willem M; Neumann, H.A. Martino // Journal of Investigative Dermatology;Feb2002, Vol. 118 Issue 2, p239 

    Photodynamic therapy with topically applied 5-aminolevulinic acid is used successfully for superficial skin lesions. The results for thicker, nodular lesions are less favorable. The method of aminolevulinic acid administration, the concentrations of aminolevulinic acid, and the irradiation...

  • Skin Scrape Cytology in the Diagnosis of Nodular Basal Cell Carcinoma for Treatment by Photodynamic Therapy. Berner, Aasmund; Soler, Ana; Warloe, Trond // Acta Dermato-Venereologica;5/26/99, Vol. 79 Issue 2, p147 

    Photodynamic therapy is a new mode of cancer treatment with promising results for basal cell carcinoma. The current study aims to investigate the accuracy of skin scrape cytology in the diagnosis of basal cell carcinoma as an integrated part of the treatment procedure. A total of 107 nodular...

  • Fractionated Illumination Significantly Improves the Response of Superficial Basal Cell Carcinoma to Aminolevulinic Acid Photodynamic Therapy. de Haas, Ellen R. M.; Kruijt, Bastiaan; Sterenborg, Henricus J. C. M.; Martino Neumann, H A; Robinson, Dominic J. // Journal of Investigative Dermatology;Dec2006, Vol. 126 Issue 12, p2679 

    Photodynamic therapy (PDT) of superficial basal cell carcinoma (sBCC) using topical 5-aminolevulinic acid (ALA) and a light fluence of 75–100 J cm−2 yields unsatisfactory long-term results. In several animal models, illumination with two light fractions 2 hours apart was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics